glucosamine

AssetAlso called Glucosamine sulphate, Glucosamine sulfate, CS+SG, GLU

Supports cartilage matrix synthesis and maintenance.

Stage
Phase 3, no development reported
Modality
Small molecule
Target
Not known
3
Indications
26
Trials
4
Developers

No development reported since August 2014. Last activity: Trial NCT01893905 completed. clinicaltrials.gov

Indications

3

In the full profile

  • Owner and partners4
  • Trials26
  • Evidence for its targets1
  • Competitors12
  • Signals15

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets